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SUMMARY
Aim: The aim of this paper is to summarise and critically evaluate the evidence available from controlled clinical
trials regarding the use of guided imagery as a sole adjuvant therapy for cancer patients.
Methods: Electronic searches for controlled clinical trials were carried out in eight databases and two clinical trial
registers. Trials that featured guided imagery as a sole adjuvant therapy were included. No language restrictions
were imposed. Data were extracted and validated independently by two researchers.
Results: Six randomised clinical trials were included. Detailed results were available for four studies only. Poor
reporting and heterogeneous populations, interventions and outcome measures across trials precluded statistical
pooling of results. The methodological quality was on average low. Three studies reported signiﬁcant diﬀerences in
measures of anxiety, comfort or emotional response to chemotherapy for patients who received guided imagery over
the control groups. Two studies showed no diﬀerences between guided imagery and other interventions in any of the
outcome measures.
Conclusion: Guided imagery, as a sole adjuvant cancer therapy may be psycho-supportive and increase comfort.
There is no compelling evidence to suggest positive eﬀects on physical symptoms such as nausea and vomiting. The
data seem suﬃciently encouraging for the use of guided imagery as an adjuvant cancer therapy to merit further
research. Copyright # 2005 John Wiley & Sons, Ltd.
INTRODUCTION
Guided imagery has recently been identiﬁed as one
of the 10 most frequently recommended comple-
mentary cancer therapies on the Internet (Schmidt
and Ernst, 2004). It is a technique used to harness
the power of the mind to form mental representa-
tions of objects, places or situations, which are
perceived through the senses (Post-White, 2002).
The term ‘visualisation’ is often used interchange-
ably with imagery. Although visual images are
most commonly evoked, sounds, smells, tastes and
sensory or aﬀective feelings may also be induced.
Guided imagery refers to the use of imagination
to invoke one or more of the senses. It involves the
‘guiding’ of an individual through experiences in
the mind, in order to access physical, emo-
tional and spiritual dimensions to aﬀect bodily
change (Achterberg, 1985). In a guided imagery
session a practitioner or other individual leads the
participant through an imagery technique or
script. This can take place in group or in one-to-
one sessions. Recordings of spoken scripts on
audiotapes are also commonly used, allowing
an individual to practise in a location of their
choosing. Individuals may also use imagery with-
out the guidance of a script. Gentle background
music often accompanies imagery sessions to help
maintain a relaxed state and to free the mind from
other thoughts.
Imagery techniques are frequently used to bring
calmness and a sense of space to alleviate anxiety
and pain (Spiegel, 1993; Lang and Patt, 1994) and
are claimed to encourage the receptivity of
treatment and facilitate the process of recovery
(Simonton et al., 1978). Guided imagery techni-
ques encourage people to feel a connection
between their mind and their body and can aid
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in facilitating feelings of empowerment in order to
help individuals manage certain diﬃculties in their
lives. Studies have suggested that guided imagery
may inﬂuence physiological outcomes such as
white blood cell count in medical patients includ-
ing cancer patients, (Donaldson, 2000), narcotic
medication requirements (Tusek et al., 1997a,b)
and other immunological eﬀects (Gruber et al.,
1993; Walker et al., 1997). Psycho-neuroimmuno-
logical theories propose that the psychological
response to guided imagery may down-regulate the
hypothalamic–pituitary–adrenal-axis, resulting in
a reduced stress response, increased immune
function and sense of well-being (Post-White,
1998). However, immune responses to emotional
stress are complex and heterogeneous (Post-White,
2002).
Guided imagery techniques vary, but generally
involve guiding the imagination towards places
(environment or situation) in which the patient
feels calm, safe, content, happy and relaxed.
Similar to meditation, guided imagery encourages
individuals to free their mind of interfering
thoughts, release their concerns from daily life
and become absorbed in the session (Post-White,
1998). Scripts have been developed to address
particular conditions or problems, which may
introduce the participant to new experiences and
enable them to break out of inﬂexible or negative
thought patterns (e.g. Post-White, 2002).
Guided imagery interventions in oncology have
focused on four areas: eﬃcacy in pain manage-
ment, inﬂuence on surgical outcomes, improve-
ment in quality of life and changes in immunity
(Lee, 1999). Speciﬁc techniques for cancer patients
may involve directing their thoughts to locations
of the tumour or metastases. The images evoked
may vary according to the technique or the
individual’s preference, from visualising a healing
light shining on the tumour or aﬀected area of the
body, to the immune system or cancer treatment
attacking and destroying cancer cells. Scripts may
address concerns over treatments, provide positive
thoughts and encourage new coping behaviours
for managing pain, anxiety and nausea (Post-
White, 2002).
The boundaries between the diﬀerent types of
mind body therapies are not easily deﬁned, and
therapies are therefore often discussed collectively
(Astin et al., 2003). Guided imagery is often used
to aid hypnosis, or meditation, or combined with
other techniques such as progressive muscle
relaxation, but the technique can also be used
alone. Relaxation is not always thought to be
necessary for guided imagery (Post-White, 2002)
although many relaxation or guided imagery
sessions incorporate elements of each practice
and use similar techniques. Previous reviews of
guided imagery trials have included combined
interventions (Wallace, 1997; Luebert et al.,
2001) but did not include all randomised-con-
trolled trials of guided imagery with cancer
patients available to date. We would argue that
the therapeutic eﬀects of guided imagery as a sole
adjuvant intervention should be evaluated in order
to clarify its role in other therapeutic regimens.
A systematic review can be viewed as a scientiﬁc
and systematic examination of the available
evidence in a speciﬁc topic (Bigby and Williams,
2003). The aim of a systematic review is to
systematically and thoroughly assess the best
possible scientiﬁc evidence about the eﬀects of a
healthcare intervention (Cochrane Library, 2004).
The method of this systematic review was based on
Cochrane Collaboration principles. Our aim was
to summarise and critically evaluate the evidence
from clinical trials for or against the use of guided
imagery as a sole adjuvant intervention with
cancer patients regarding any physical or psycho-
logical change. We asked the following research
questions:
Are there beneﬁts to cancer patients from the
use of guided imagery as a sole adjuvant therapy?
What does the evidence from controlled clinical
trials suggest regarding the eﬀectiveness of ima-
gery as an adjuvant cancer therapy? What out-
come measures have been tested and are they
appropriate? What is the methodological quality
of the studies?
METHOD
Systematic literature searches were performed to
identify all randomised controlled clinical trials in
which an imagery intervention was applied to
cancer patients. The following electronic databases
were searched from their inception until March
2004: the Allied and Complementary Medicine
Database (inception 1985), the British Nursing
Index (1994), CancerLit, CINAHL (1983), Cur-
rent Controlled Clinical Trials Register (inception
1998), DH-DATA (1983), EMBASE (1966), ISI
Web of Science (inception 1975), MEDLINE
(1966), National Research Register (inception
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2000) and PSYCHINFO (1987). The search terms
used were cancer or oncolog$ or carcinogen$ or
tumo$r and imagery or visualisation or visualisa-
tion. Reference lists of reviews and our depart-
mental ﬁles were hand-searched for additional
trials.
Studies were required to include a control
group. No restrictions were placed on the lan-
guage, place or year of publication. The terminol-
ogy used in the primary reports was used to
determine and distinguish between the types of
therapies. Articles were included if they speciﬁed
the use of guided imagery, imagery or visualisation
with cancer patients as a sole adjuvant interven-
tion to standard or palliative cancer care or as a
sole supportive intervention in cancer patients
who were not concurrently undergoing treatment.
There were no restrictions placed on the site
or stage of cancer. Studies in which the guided
imagery intervention was described as occurring
in a support group environment, or as guided
imagery combined with any other therapy or
coping package, such as hypnosis, relaxation
therapy, music therapy, cognitive behavioural or
any other coping package were excluded.
Data were extracted independently from each
paper by two reviewers (L.R., K.S.) and veriﬁed by
a third reviewer (E.E.) according to pre-deﬁned
criteria. The methodological reporting of the
studies was assessed using the Jadad score (Jadad
et al., 1996). The Jadad score was calculated by
assessing three criteria: blinding and description
of the method of blinding, randomisation and
description of the method of randomisation
and reporting of dropouts and/or withdrawals.
The maximum number of points that can be
achieved on the Jadad score is 5. In guided
imagery it is impossible to blind patients, as it
will be obvious whether an intervention was
received or not. However, one point was given
for blinding if the outcome assessor was blinded.
The validity of each trial was assessed according
to a previously published score ranging from
0 (minimum validity) to 3 (maximum validity)
where one point was given for a positive answer to
each one of the following questions: (1) Was the
study sample relevant? (2) Was the intervention
appropriate? (3) Was the outcome measure suita-
ble? (Ernst, 2002). The heterogeneity of popula-
tions, interventions and outcome measures across
trials precluded statistical pooling of results.
Results were therefore tabulated and described
narratively.
RESULTS
The literature searches located 103 articles inves-
tigating guided imagery for cancer patients. From
these, 97 studies did not meet the inclusion criteria.
The remaining six trials were included in the
review. Figure 1 summarises the exclusion process.
Examples of some of the more relevant but
nevertheless excluded trials are six RCTs that
assessed the eﬀects of guided imagery in combina-
tion with relaxation techniques in cancer patients
(Burish et al., 1991; Gruber et al., 1993; Arathuzik,
1994; Richardson et al., 1997; Walker et al., 1999;
Xie-Zhong, 2001). Five RCTs combined guided
imagery with progressive muscle relaxation in the
experimental group (Burish and Lyles, 1981; Lyles
et al., 1982; Syrjala et al., 1995; Liu et al., 2001;
Baider et al., 2001). Two RCTs combined guided
imagery with music therapy (Xie-Zhong, 2001;
Burns, 2002). One other RCT combined guided
imagery with hypnosis or meditation in the
experimental group (Rapkin et al., 1991; Targ
and Levine, 2002).
Furthermore, four ongoing or completed
RCTs in the UK were located from the National
Research Register (http://www.update-software.
com/national/), of which the majority are com-
bined interventions. These assess the eﬃcacy of
guided imagery in cancer patients undergoing
surgery for colorectal cancer (completed project
R Molloy, Department of Surgery, Gartnavel
General Hospital, Glasgow; http://www.update-
software.com/national/); evaluate the beneﬁts of
guided imagery and relaxation in cancer patients
through a comparison of immune-targeted and
non-speciﬁc imagery (ongoing project, M Spencer,
Consultant in General Adult Psychiatry, Rydon
House, Taunton (http://www.update-software.-
com/national/); assess the Psycho-neuroimmuno-
logical eﬀects of relaxation and guided imagery
alone and in combination with other interventions
in patients with colorectal cancer (ongoing project,
P Mack and L Walker, Institute of Rehabilitation,
Hull; http://www.update-software.com/national/)
and assess Quality of Life and psycho-neuroim-
munological eﬀects of reﬂexology, relaxation and
guided imagery in patients with lung cancer
(Lesley Walker).
Only four of the included studies were published
in their entirety. Two studies were published as
abstracts only (Post-White, 1996; Kwekkeboom,
1999). The authors were contacted but due to
unpublished material the results from these studies
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were not available and could therefore not be
evaluated. These studies are discussed narratively
only. The extracted data from all included trials
are presented in Table 1.
Five included studies were carried out in the
USA between 1990 and 1999 and one was under-
taken in Israel in 2002. All six studies were
randomised controlled clinical trials, but none
were outcome assessor blinded. All six trials
adopted a parallel group design. In all trials
patients in the experimental group received an
imagery intervention additional to standard cancer
care or palliative care. Patients in the control
groups received standard care only, except in one
study (Sloman, 2002), in which all patients
received palliative care and the control condition
was an ‘attention’ control where a nurse or
practitioner spent an equivalent amount of time
with patients but provided no speciﬁc therapeutic
intervention. Three studies compared the guided
imagery intervention with a standard care control
only (Troesch et al., 1993; Kolcaba and Fox, 1999;
Kwekkeboom, 1999), whereas three studies
included other intervention groups such as pro-
gressive muscle relaxation, hypnosis, support or a
combination of guided imagery and one of the
above named interventions (Feldman and Salz-
berg, 1990; Post-White, 1996; Sloman, 2002).
Sample sizes ranged from 30 to 75 cancer
patients. Dropouts and withdrawals were men-
tioned in three studies (Troesch et al., 1993;
Kolcaba and Fox, 1999; Kwekkeboom, 1999).
All participants had previously been diagnosed
with cancer and cancer types included newly
diagnosed cancer, advanced primary or metastatic
cancer, and early stage I or II breast cancer
(Table 1). The ages of participants were reported
in three studies (Troesch et al., 1993; Kolcaba and
Fox, 1999; Sloman, 2002) and varied across the
studies from 27 to 81 years. Gender was speciﬁed
in all but one study (Troesch et al., 1993); two
studies included both males and females, and in
three studies participants were all female.
A variety of self-report measures were used to
assess the eﬀect of guided imagery, including
anxiety, depression, quality of life, comfort, pain,
nausea and vomiting, and overall chemotherapy
experience. These outcomes were assessed using
103 studies 
located that were 
relevant to guided 
imagery 
Imagery 
combined 
with other 
treatments
(n=56)
Uncontrolled trials
(n=12)
Non-randomised
trial 
(n=2)
Imagery case 
studies
(n=27)
6 studies 
included
Figure 1. Flowchart of excluded studies including cancer patients.
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validated questionnaires, such as the State Trait
Anxiety Inventory (STAI), the Hospital Anxiety
and Depression Scale (HADS), the Functional
Living Index Cancer Scale (FLICS), Post-che-
motherapy State Anxiety Scale (PCSTAS), and the
Rhodes Index of Nausea and Vomiting Form 2,
and non-validated tools such as the Chemotherapy
Experience survey, and the Radiation Therapy
Comfort questionnaire. One abstract only study
additionally measured immune function (Post-
White, 1996). Two studies investigated physiolo-
gical outcomes such as heart rate and occurrence
of nausea and vomiting (Feldman and Salzberg,
1990; Troesch et al., 1993). In three studies,
patients were undergoing chemo- or radiotherapy;
in one study patients were undergoing surgery and
in another trial patients were receiving palliative
care but had no other intervention. Additional
cancer treatments included pain medication such
as morphine and other antiemetic medication. In
one study, published as an abstract only, patients
had completed treatment; thus, imagery was
strictly a supportive rather than an adjuvant
therapy. This study was included as it met all
other inclusion criteria but results were not
available, and therefore it was not included in
the evaluation (Post-White, 1996). All four studies
published in full state that guided imagery training
sessions were held either once or up to three times
during duration of the trial, and duration of
sessions varied from 12 to 60min (Feldman and
Salzberg, 1990; Troesch et al., 1993; Post-White,
1996; Sloman, 2002). No adverse eﬀects of guided
imagery were reported in any of the studies. The
included studies are narratively described in the
following section.
SUMMARIES OF INCLUDED STUDIES
Feldman and Salzberg assessed the eﬀects of
guided imagery on adverse reactions to cancer
therapy in a randomised clinical study (Feldman
and Salzberg, 1990). Sixty cancer outpatients who
had recently received at least one cycle of
chemotherapy were randomised into one of the
following groups (a) guided imagery, (b) hypnosis,
(c) hypnosis-imagery or (d) standard care. The
intervention groups received training sessions, in
which an experimenter brieﬂy introduced the
intervention before inducing a trance by describingTr
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structured images before administering che-
motherapy. Measurements were taken before,
after and 24 h following each administration of
chemotherapy using the STAI and self-reports of
anxiety, nausea and emesis. Results showed a
signiﬁcant group by time interaction for all groups
for the post-chemotherapy STAI, F (6,112)=2.40,
P=0.03. Additionally, signiﬁcant group diﬀer-
ences between the three intervention groups and
the control group for the STAI were detected,
F (1, 78)=7.14, P=0.008. No signiﬁcant diﬀer-
ences were shown between the three diﬀerent
interventions or between the control group and
hypnosis-imagery group, the guided imagery
group or the hypnosis group alone. This study
achieved one out of ﬁve Jadad points. No blinding
of the outcome assessor or method of randomisa-
tion was reported.
Kolcaba and Fox studied the eﬀects of GI on
comfort in a randomised clinical study of 53
women with early stage breast cancer who were
about to undergo radiation therapy (Kolcaba and
Fox, 1999). The State Anxiety Inventory was used
as a baseline measure of anxiety. The primary
outcome measure was the Radiation Therapy
Comfort questionnaire. This instrument together
with the guided imagery script was developed for
the study by the authors to address all aspects of
comfort. The script included references to the
machinery and physical environment involved in
the treatment, and to a healing white light.
Measurements were taken three times: (1) at
baseline, (2) three weeks after radiation therapy
commenced and (3) three weeks after radiation
therapy ended. The results indicated that in both
groups overall comfort increased over a 6-week
time period. Signiﬁcantly higher levels of comfort
were reported in the guided imagery group
compared to the control group, F (1, 51)=4.33,
p50.05 over the three measurement points. The
strongest eﬀect occurred at measuring three weeks
after radiation therapy commenced (D2=0.55,
p5 0.05). This study received two points on the
Jadad score for methodological quality of the
study. No blinding of the outcome assessor was
reported.
Kwekkeboom carried out a randomised clinical
trial to assess the role of imaging ability in the use
of GI for cancer related pain (Kwekkeboom,
1999). Seventy-ﬁve women undergoing surgery
for breast or gynaecologic cancers were rando-
mised to receive either a GI intervention addition-
ally to standard cancer care or only standard care
control. The standard care control also allowed
the use of analgesic medication. The GI interven-
tion consisted of a 12-min relaxation tape with
nature and relaxation images. Pain severity,
distress and interference were the primary outcome
measures. No signiﬁcant diﬀerences were reported
regarding the therapeutic eﬀect of GI. Full results
for this study were not available, as it was
published only as dissertation abstract. Therefore,
results could not be evaluated and the Jadad
scoring system could not be applied to this paper.
Post-White et al. investigated the psycho-im-
mune response to imagery and support in 73
female breast cancer survivors who had completed
treatment for breast cancer within the past two
years (Post-White, 1996). Participants were ran-
domly assigned to an imagery group (‘guided’
imagery not speciﬁed), a support group or a
standard care control group. Intervention groups
met weekly for one and a half hours over a period
of 8 weeks. Emotional state, fatigue, quality of life
and immune responses were measured, however,
no statistical analysis was reported. Again, this
study is currently only available as a dissertation
abstract. Therefore, the results could not be
evaluated and the Jadad scoring system could
not be applied to this paper.
In a randomised clinical trial, Sloman investi-
gated the eﬀect of guided imagery on quality of
life, anxiety and depression in patients with
advanced cancer (Sloman, 2002). All 56 partici-
pants were receiving palliative care in their homes
and were on pain medication. Participants were
randomised into four groups (a) guided imagery,
(b) progressive muscle relaxation (PMR), (c) PMR
and guided imagery or (d) attention control
whereby nurses endeavoured giving patients an
equal amount of attention as patients in the
intervention group. Participants initially received
a 30min session with a trained practitioner or
nurse, followed by practice with an audiotape
twice per day (for the intervention groups) and
follow up sessions with the practitioner twice per
week. Pre-test versus post-test comparisons were
carried out three weeks after the initial session
with the practitioner. Outcome measures included
the Hospital Anxiety and Depression Scale, and
the Functional Living Index}Cancer Scale. There
were no signiﬁcant diﬀerences in the anxiety scores
between any of the groups. Comparisons of mean
depression and quality of life scores showed that
none of the three treatment groups signiﬁcantly
diﬀered from each other but that each treatment
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group was signiﬁcantly diﬀerent from the control
group for both depression and quality of life (no
statistics available). A signiﬁcant overall group
eﬀect of the three interventions was reported for
depression (F=4.639, p50.01) and quality of life
(F= 4.979, p50.01). The methodological quality
of the study achieved one point on the Jadad score.
No blinding of the outcome assessor or method of
randomisation was reported.
Troesch et al. investigated the inﬂuence of GI on
chemotherapy-related nausea and vomiting in a
randomised clinical trial of 28 newly diagnosed
cancer patients receiving the antineoplastic agent
Cisplatin as a part of their chemotherapeutic
regimen (Troesch et al., 1993). Patients were
randomised into the experimental group, which
received GI, or the control group, which received
standard care alone. The experimental group was
given instructions on the GI intervention from the
researcher, followed by 20-min sessions using a
positive experience GI audiotape. Participants
practised with the tape three times: 60min before
their chemotherapy session in the clinic, at home
the following morning before breakfast and in the
evening of the same day at bedtime. The study
investigators assessed nausea and vomiting with
the Rhodes Index of Nausea and Vomiting Form
2, which measures patients’ perceived duration,
frequency and distress of dry heaves. Data from
hospital records were collected using the Subject
Demographics and Emetic Response Tool. This
included nurses’ documentation of the frequency
and severity of nausea and vomiting. However,
complete results were not reported. Findings
showed no statistically signiﬁcant diﬀerences
between the groups at any of the ﬁve measured
times during chemotherapy administration. The
Chemotherapy Experience survey was used to
evaluate participants’ overall perceptions of the
chemotherapy. The GI group expressed a signiﬁ-
cantly more positive experience with chemother-
apy compared to the control group (P=0.0326).
Two points were given to this study on the Jadad
scale. No blinding of the outcome assessor was
reported.
DISCUSSION
Results from both the two-armed trials showed
beneﬁts in the guided imagery intervention groups
compared to standard care control groups;
signiﬁcant eﬀects were found in emotional re-
sponse to chemotherapy (Troesch et al., 1993) and
comfort during radiotherapy (Kolcaba and Fox,
1999). Signiﬁcant eﬀects were also reported for all
interventions in both the four-armed trials, in
which treatment groups included hypnosis or
relaxation techniques and combined interventions
in addition to guided imagery alone (Feldman and
Salzberg, 1990; Sloman, 2002). These studies
showed positive group eﬀects for all intervention
groups on depression, quality of life and anxiety
over a control or attention control group, but
there were no signiﬁcant diﬀerences between
interventions. One four-armed study also reported
signiﬁcant diﬀerences between each intervention,
and the control in both depression and quality of
life, but no statistics were reported (Sloman, 2002).
Guided imagery did not have a signiﬁcant eﬀect on
physical symptoms, such as nausea or vomiting. A
low incidence of symptoms at baseline may
provide a reason for this in one study (Feldman
and Salzberg, 1990).
Collectively, these data suggest that guided
imagery may be beneﬁcial as a psycho-supportive
adjuvant therapy for cancer patients. Several
caveats, however, apply. Certain aspects of report-
ing were inadequate in all trials. The often-low
scores on the Jadad scale present a possible
tendency toward bias. Details of the subject matter
in the guided imagery scripts were only reported in
three studies (Troesch et al., 1993; Kolcaba and
Fox, 1999; Kwekkeboom, 1999) and, with the
exception of one study (Kolcaba and Fox, 1999),
explicit descriptions of the intervention procedures
and duration were lacking. The often poor
reporting of the studies available for review
renders ﬁrm conclusions problematic.
The stages at which patients practised the
interventions in their treatment regimen varied,
as did the amount of time spent practising and the
timing of measurements. Two studies reported
time eﬀects, for post chemotherapy anxiety and for
comfort during radiotherapy (Feldman and Salz-
berg, 1990; Kolcaba and Fox, 1999). A recent
meta-analysis suggested that the eﬀect size of
guided imagery increased over the ﬁrst ﬁve to
seven weeks but decreased at 18 weeks. (Van
Kuiken, 2004). The authors also found that more
detailed reporting of imagery practise and out-
come measures is needed in further trials.
Most studies presented here incorporated the
use of audiotapes with guidance by a nurse,
practitioner or experimenter The use of audiotapes
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is often favoured over face-to-face sessions with a
practitioner in order to reduced costs. From a
research perspective, this also has the beneﬁt of
reducing any context eﬀect or inﬂuence of a
personal interaction on the perceived beneﬁt of
the guided imagery technique itself. However,
adherence to the intervention may be harder to
achieve or assess in this situation. Only one study
(Kolcaba and Fox, 1999) described monitoring
patients’ compliance with carrying out the inter-
ventions as required by the study. The use of a
support group or attention control in one study
(Sloman, 2002) is commended as an attempt to
control for context eﬀects.
There were no adverse eﬀects reported in any of
the trials, but there was a lack of reporting in all
but one study (Sloman, 2002) about whether any
opportunities were given for comments or follow
up discussions with a practitioner. It has been
noted that ambiguous sensations can be evoked
during guided imagery, which people may inter-
pret very diﬀerently (Graham, 1990). The oppor-
tunity for patients to discuss their feelings and the
issues raised by guided imagery, may help people
acknowledge and interpret their feelings (Post-
White, 2002). This may also inﬂuence their
perceptions of the therapy session and contribute
to the eﬀectiveness of the intervention. This, again,
highlights the importance of careful planning,
conducting and reporting of trials.
Confounding variables such as sleep, diet and
exercise together with imaging ability and expecta-
tions about the intervention may inﬂuence the
results of clinical trials (Kwekkeboom et al., 1988)
and measuring feelings and perceptions is fraught
with diﬃculty. Many studies that have investigated
the eﬀectiveness of imagery lack the scientiﬁc
rigour of randomised controlled trials. Physiolo-
gical measures provide objective and reliable
measurements, which usually satisfy rigorous
scientiﬁc enquiry, however, individuals’ needs
and reasons for using imagery may vary greatly
from one another and cannot always be reﬂected
by such measures. The impact of an intervention
on quality of life issues such as the experience of
treatment, perceived relaxation or anxiety, or a
sense of control can only be assessed by self-
reports. It is therefore important that outcome
measures employed to quantify such eﬀects are
adequately validated. A social desirability eﬀect,
whereby patients report positive responses to
please the experimenter may contribute to posi-
tive results (Krosnick, 1999) particularly, when
questionnaires are not validated, as in two of the
included trials (Troesch et al., 1993; Kolcaba and
Fox, 1999). The sensitivity of frequently used
diagnostic scales such as the HADS is also
uncertain when employed in diﬀerent clinical
populations (Love et al., 2002). The HADS has
been found to be less accurate for those with
progressive disease (Ibbotson et al., 1994), yet this
is the population it was applied to in one study
(Sloman, 2002).
There is no single standard method or script for
guided imagery treatment and there is currently no
evidence to suggest that one form of guided
imagery is more eﬀective than another (Post-
White, 2002). Techniques employed in the re-
viewed studies were, where described, varied, and
the nature of the therapy allows practitioners and
participants to modify their practise to suit
circumstances and individual requirements. Due
to the highly personalised and experiential nature
of the therapy, patients are currently faced with a
‘trial and error’ approach to selecting a technique,
and are dependent on the good judgment of a well-
trained and experienced practitioner.
In the two four-armed trials, no diﬀerences were
found between the results of groups who received
other interventions and those who received guided
imagery as a sole adjuvant intervention; nor were
there diﬀerences between the GI groups and those
who received hypnosis or progressive muscle
relaxation, in addition to GI. These results suggest
there may be no diﬀerences between guided
imagery as a sole intervention than when com-
bined with other interventions such as relaxation
or hypnosis for outcomes such as anxiety, depres-
sion or quality of life.
The relatively small number of studies that have
investigated the eﬀect of guided imagery as a sole
adjuvant therapy may be a reﬂection of practice.
Boundaries between the various types of mind
body therapies are blurred and combinations of
techniques are frequently employed according to
the practitioner and the user. However, for a clear
evaluation, individual therapies, (ideally individual
techniques) also need to be assessed in isolation.
Given the widespread use of guided imagery and
its popularity, sample sizes were small and lacked
suﬃcient power to produce widely applicable
results.
Questions regarding individual diﬀerences and
the inﬂuence of imagery content on eﬀect size and
immune response, as raised by Post-White and
Fitzgerald (2002) still remain to be answered.
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Further research comparing diﬀerent interven-
tions, techniques (such as ‘pleasant’ imagery and
‘targeted’ imagery) and procedures (such as the
timing of practise and number of sessions) and
accompanied by qualitative data may reveal richer
data regarding the suitability of techniques. This
will enable the practitioner to address the indivi-
dual needs of cancer patients from general quality
of life or to a more direct approach to dealing
with, for example, treatment related anxiety or
adverse eﬀects. The use of more sensitive tools and
a combination of qualitative and quantitative
methods might reveal subtle but important diﬀer-
ences experienced by cancer patients. Limitations
of this review include the diﬃculty involved in
deﬁning ‘imagery’ for the inclusion/exclusion
criteria; and this was doubly problematic when
the reporting of imagery techniques was unclear
and lacked details regarding whether an interven-
tion was adjuvant to standard oncological treat-
ment. Even though our search strategy was
thorough, we cannot be certain to have located
all relevant trials. As the number of included
studies is small, missing even one or two studies
could alter the conclusion of this review. Further-
more, one-third of the included studies were only
available in abstract form, which prevented any
evaluation of their results.
In conclusion, guided imagery as a sole adjuvant
cancer therapy may be psycho-supportive and
increase comfort. There is, however, no signiﬁcant
evidence from trials to suggest positive eﬀects on
physical symptoms such as nausea and vomiting.
The paucity and low methodological quality of the
primary data allow only tentative conclusions.
However, the evidence available to date seems
suﬃciently encouraging for the use of guided
imagery and merits further study.
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